Physicochemical and pharmacological investigation of water/oil microemulsion of non-selective beta blocker for treatment of glaucoma

Current Eye Research

Volumn 39, Issue 2, 2014, Pages 155-163

  Hegde, Rahul Rama ^a   Bhattacharya, Shiv Sankar ^a   Verma, Anurag ^a   Ghosh, Amitava ^b  

^a IFTM UNIVERSITY   (India)

^b West Bengal University of Technology   (India)

Author keywords

Glaucoma; Ocular bioavailability; Phase transition; Timolol maleate; Water oil microemulsion

Indexed keywords

EYE DROPS; POLYSORBATE; SODIUM CHLORIDE; TIMOLOL MALEATE; WATER; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COLLOID; EMULSION; OIL; SURFACTANT; TIMOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; ARTIFICIAL MEMBRANE; CONTROLLED STUDY; CORNEA; DIFFUSION; DRUG DIFFUSION; DRUG EFFICACY; DRUG PENETRATION; DRUG RELEASE; DRUG STABILITY; ELECTRIC CONDUCTIVITY; EX VIVO STUDY; EXPERIMENTAL GOAT; EYE INFLAMMATION; EYE IRRITATION; FINITE ELEMENT ANALYSIS; FLOW KINETICS; GLAUCOMA; IN VITRO STUDY; IN VIVO STUDY; INTRAOCULAR PRESSURE; MICROEMULSION; NONHUMAN; OSMOLALITY; PARTICLE SIZE; PH; PHASE TRANSITION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SURFACE TENSION; ZETA POTENTIAL; ANIMAL; BIOAVAILABILITY; CHEMISTRY; COLLOID; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG EFFECTS; ELECTRIC CAPACITANCE; EMULSION; GOAT; INFRARED SPECTROSCOPY; METABOLISM; RABBIT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BIOLOGICAL AVAILABILITY; COLLOIDS; CORNEA; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; ELECTRIC CAPACITANCE; EMULSIONS; GLAUCOMA; GOATS; INTRAOCULAR PRESSURE; OILS; PARTICLE SIZE; POLYSORBATES; RABBITS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE-ACTIVE AGENTS; TIMOLOL; WATER;

EID: 84892965108     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2013.833630     Document Type: Article

References (31)

1. Blomdahl S, Calissendorff BM, Tengroth B, Wallin O. Blindness in glaucoma patients. Acta Ophthalmol Scand 1997;75:589-591.
2. Munier A, Gunning T, Kenny D, O'Keefe M. Causes of blindness in the adult population of the Republic of Ireland. Br J Ophthalmol 1998;82:630-633.
3. Friedman DS, Wolfs RC, O'Colmain BJ, Klein BE, Taylor HR, West S. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol 2004; 122:532-538.
4. Lawrence MJ. Microemulsions as drug delivery vehicles. Curr Opin Colloid Interface Sci 1996;1:826-832.
5. Saettone MF, Chetoni P, Cerbai R, Mazzanti G, Braghiroli L. Evaluation of ocular permeation enhancers: In vitro effects on corneal transport of four b-blockers, and in vitro/in vivo toxic activity. Int J Pharm 1996;142:103-113.
6. Burgalassi S, Chetoni P, Monti D, Saettone MF. Cytotoxicity of potential ocular permeation enhancers evaluated on rabbit and human corneal epithelial cell lines. Toxicol Lett 2001;122:1-8.
7. Chetoni P, Burgalassi S, Monti D, Saettone MF. Ocular toxicity of some corneal penetration enhancers evaluated by electrophysiology measurements on isolated rabbit corneas. Toxicol In Vitro 2003;17:497-504.
8. Gasco MR, Gallarate M, Trotta M, Bauchiero L, Gremmo E, Chiappero O. Microemulsions as topical delivery vehicles: Ocular administration of timolol. J Pharm Biomed Anal 1989;7:433-439.
9. Thomson Physicians' Desk Reference, 62nd ed. Wadsworth; Montvale, NJ: Thomson PDR Network; 2008.
10. Katragadda S, Talluri RS, Mitra AK. Modulation of P-Glycoprotein-mediated efflux by prodrug derivatization: An approach involving peptide transportermediated influx across rabbit cornea. J Ocular Pharmacol Ther 2006;22: 110-120.
11. Chan J, Maghraby GMMEl, Craig JP, Alany RG. Phase transition water-in-oil microemulsions as ocular drug delivery systems: In vitro and in vivo evaluation. Int J Pharm 2007;328:65-71.
12. Alany RG, Rades T, Nicoll J, Tucker IG, Davies NM. W/O microemulsions for ocular delivery: Evaluation of ocular irritation and precorneal retention. J Control Release 2006;11:145-152.
13. Gupta H, Jain S, Mathur R, Mishra P, Mishra AK, Velpandian T. Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system. Drug Deliv 2007;14:507-515.
14. Muchtar S, Abdulrazik M, Pery JF, Benita S. Ex-vivo permeation study of indomethacin from a submicron emulsion through albino rabbit cornea. J Control Release 1997;44:55-64.
15. Yang SC, Benita S. Enhanced absorption and drug targeting by positively charged submicron emulsions. Drug Develop Res 2000;50:476-486.
16. Zhu MD, Cai FY. Development of experimental chronic intraocular hypertension in the rabbit. Aust Nz J Ophthalmol 1992;20:225-234.
17. Hariton C, Marce D, Debon C. Transitory models of experimentally induced intraocular pressure changes in the rabbit. A reappraisal. J Pharmacol Method 1990;24: 79-88.
18. Ammar HO, Salama HA, Ghorab M, Mahmoud AA. Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride. AAPS Pharm Sci Tech 2009;10:808-819.
19. Alany RG, Tucker IG, Davies NM, Rades T. Characterizing colloidal structures of pseudoternary phase diagrams formed by oil/water/amphiphile systems. Drug Dev Ind Pharm 2001;27:31-38.
20. Corswant CV, Engstrom S, Soderman O. Microemulsions based on soybean phosphatidylcholine and triglycerides. phase behavior and microstructure. Langmuir 1997;13: 5061-5070.
21. Chen SJ, Evans DF, Ninham BW, Mitchell DJ, Blum FD, Pickup S. Curvature as a determinant of microstructure and microemulsions. J Phys Chem 1986;90:842-847.
22. Sripriya R, Raja KM, Santhosh G, Chandrasekaran M, Noel M. The effect of structure of oil phase, surfactant and co-surfactant on the physicochemical and electrochemical properties of bicontinuous microemulsion. J Colloid Interface Sci 2007;314:712-717.
23. Fialho SL, Cunha SA. New vehicle based on a microemulsion for topical ocular administration of dexamethasone. Clin Experiment Ophthalmol 2004;32:626-632.
24. Trotta M, Gasco MR, Morel S. Release of drugs from oil-water microemulsions. J Control Release 1989;10: 237-243.
25. Sasaki H, Ichikawa M, Kawakami S, Yamamura K, Mukai T, Nishida K. In-situ ocular absorption of ophthalmic beta-blockers through ocular membranes in albino rabbits. J Pharm Pharmacol 1997;49:140-144.
26. Cho YH, Kim S, Bae EK, Mok CK, Park L. Formulation of a cosurfactant-free o/w microemulsion using nonionic surfactant mixtures. J Food Sci 2008;73: E115-121.
27. Hickey S, Hagan SA, Kudryashov E, Buckin V. Analysis of phase diagram and microstructural transitions in an ethyl oleate/water/Tween 80/Span 20 microemulsion system using high-resolution ultrasonic spectroscopy. Int J Pharm 2010;388:213-222.
28. Hegde RR, Kumar S, Aswal VK, Verma A, Bhattacharya SS, Ghosh A. Small angle neutron scattering study of non ionic surfactant micelles and phase transitions in w/o microemulsion J Disper Sci Technol 2013 (In-Press).
29. Klang SH, Frucht-Pery J, Hoffman A, Benita S. Physicochemical characterization and acute toxicity evaluation of a positively-charged submicron emulsion vehicle. J Pharm Pharmacol 1994;46:986-993.
30. Benita S. Prevention of topical and ocular oxidative stress by positively charged submicron emulsion. Biomed Pharmacother 1999;53:193-206.
31. Habe A, Keipert S. Development and characterization of microemulsions for ocular application. Eur J Pharm Biopharm 1997;43:179-183.